How Are Non-Conformances Addressed in Chinese Drug Quality Audits?

In Chinese drug quality audits, non-conformances are addressed through corrective and preventive actions (CAPA). Companies must investigate root causes, implement corrective measures, and document actions taken. Regulatory authorities may conduct follow-up inspections to ensure compliance. Continuous monitoring and staff training are emphasized to prevent recurrence and maintain quality standards.

Leave a Reply

You must be logged in to post a comment.